Svitlana Bach, Ph.D. joined Lieber as a postdoctoral fellow working in Dr. Keri Martinowich’s in January 2020. She was promoted to staff scientist in November 2021. She is interested in developing novel genome editing tools to find new therapeutic strategies for neurodegenerative disorders, such as Alzheimer’s disease. Her prior work in Dr. Jeremy Day’s laboratory at the University of Alabama at Birmingham focused on the development and optimization of the CRISPR/dCas9 system to investigate structural and functional roles of different transcript variants of the Brain-derived neurotrophic factor (Bdnf) gene in the nervous system. She received her Ph.D. from Wake Forest School of Medicine where she worked in Dr. Ashok Hegde’s laboratory studying protein degradation mechanisms by the ubiquitin-proteasome pathway (UPP) in synaptic plasticity. Her dissertation work focused on proteolytic and non-proteolytic (epigenetic) roles of the UPP in modulating long-term potentiation, a model of learning and memory. She received her B.S. in psychology with minors in both chemistry and biology from New Mexico Highlands University, where her undergraduate research focused on synthesis and structural investigations of organic compounds.